---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-005473"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:58:54.973548+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# STERIS Q3 revenue +9% to $1.5B; adj EPS $2.53 beats prior year $2.32; FY2026 outlook maintained

## Summary
- Revenue $1.5B (+9% YoY); constant currency organic revenue growth 8%.
- Reported EPS from cont ops $1.96; adjusted EPS $2.53 vs $2.32 last year.
- Healthcare revenue $1.1B (+9%), AST $286.6M (+11%), Life Sciences $145.8M (+7%).
- Free cash flow first 9 months $737.6M vs $588.1M prior year period.
- FY2026 adj EPS guidance reaffirmed $10.15-10.30; tariff headwind increased to ~$55M.

## SEC filing metadata
- accession: 0001628280-26-005473
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000162828026005473/0001628280-26-005473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000162828026005473/ste-20260204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-005473
- JSON: https://secwatch.observer/filing/0001628280-26-005473.json
- Plain text: https://secwatch.observer/filing/0001628280-26-005473.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.